Dr. Miguel Sobral is an Associate at Longwood Fund where he is involved in creating and supporting portfolio companies. Miguel was previously a Fellow at Vida Ventures, where he performed scientific and clinical diligence on early-to-mid-stage investment opportunities across numerous therapeutic areas. Miguel completed his graduate studies in bioengineering with Dr. David Mooney at Harvard University, where he was a NSF Graduate Research Fellow. His research, which focused on developing biomaterial scaffold-based therapeutic cancer vaccines, resulted in multiple publications in several peer-reviewed journals. Prior to his doctorate, Miguel received his B.S. in Biomedical Engineering from Johns Hopkins University, where he graduated with honors and received a Barry M. Goldwater Scholarship.